Synthetic Biologics, Inc. (SYN)
EBITDA
-$9.67M
TTM · Period ending: · USD
SYN EBITDA
Latest reported-$9.67Mperiod ending
Latest reported-$9.67Mperiod ending
SYN TTM EBITDA (-$1.95M → -$9.67M)
TTM EBITDA
High-resolution chart · PNG
SYN ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -3,800,000 | |
| -4,800,000 | |
| -5,400,000 | |
| -6,100,000 | |
| -8,700,000 | |
| -9,200,000 | |
| -9,800,000 | |
| -9,500,000 | |
| -7,800,000 | |
| -6,800,000 | |
| -6,600,000 | |
| -7,180,000 | |
| -7,470,000 | |
| -7,260,000 | |
| -7,080,000 | |
| -6,550,000 | |
| -6,200,000 | |
| -5,110,000 | |
| -4,590,000 | |
| -4,440,000 | |
| -3,300,000 | |
| -3,300,000 | |
| -2,620,000 | |
| -1,310,000 | |
| -1,460,000 | |
| -1,950,000 |